This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Bioinfobank Sp. Z O. O., Institute of Bioorganic Chemistry, Uniwersytet Medyczny Im. Karola Marcinkowskiego. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 2 
1 out of 8 
1 out of 3 Years Active: 2015
Title: The Innovative Mind of Ryszard Zukiel: Advancements in Brain Tumor Treatment
Introduction
Ryszard Zukiel is a distinguished inventor based in Poznan, Poland, known for his groundbreaking contributions to medical science. With a focus on innovative treatments for brain tumors, Zukiel holds a patent that is pivotal in the field of oncology, specifically targeting the malignant gliomas prevalent in patients.
Latest Patents
Zukiel's notable patent is for a sequence of double-stranded RNA known as ATN-RNA, which demonstrates significant potential in the treatment of brain tumors. This patent covers various facets of his invention, including the use of interference RNA (iRNAi) to inhibit tumor cells expressing tenascin-C. The invention presents a method not only for treating brain tumors but also for creating kits meant for brain tumor therapy, utilizing RNA interference techniques to target tenascin-C—a glycoprotein associated with tumor cell behavior.
Career Highlights
Throughout his career, Ryszard Zukiel has associated with prestigious institutions, including the Institute of Bioorganic Chemistry and the Karol Marcinkowski Medical University. These affiliations have greatly influenced his research and development in the realm of cancer therapies. His work focuses on exploiting surface markers, particularly tenascin-C, to create therapeutic interventions for malignant gliomas.
Collaborations
Zukiel has collaborated with notable researchers such as Jan Barciszewski and Miroslawa Barciszewska. These partnerships have enhanced the investigative depth of his projects, allowing for a holistic approach to cancer treatment and an expansion of his innovative ideas into practical applications.
Conclusion
Ryszard Zukiel's contributions to the field of medical science, particularly in the treatment of brain tumors, highlight the importance of innovation in healthcare. His patent for the ATN-RNA sequence signifies a promising avenue for cancer therapies and exemplifies the potential that lies within research and collaboration in scientific advancements. As treatments evolve, the legacy of inventors like Zukiel continues to inspire new generations in the quest for effective medical solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile